Kimberly practices in product liability complex litigation, with a focus on life sciences and health matters. She is also a registered patent attorney. With extensive experience in managing litigations from early case assessments through appeals and in working with other attorneys in a virtual law firm, Kimberly knows the importance of developing a close partnership with clients and co-counsel to ensure a seamless integration of science-based defenses into the overall litigation strategy. Her knowledge of science, including an undergraduate degree in natural sciences from Johns Hopkins as well as three master's degrees in biochemistry, sociology and genomics, allows her to research, work with experts, and incorporate compelling scientific, mechanistic, and physiological arguments into successful defense strategies. Not only does Kimberly have experience incorporating in-depth science investigations into affirmative defense strategies, she regularly conducts effective depositions of plaintiffs’ experts, often leading to successful exclusions of plaintiffs’ experts from trial. Additionally, Kimberly has prepared and defended numerous experts and company science witnesses for depositions. Life sciences product liability cases Kimberly has defended include DES, Provera, anxiolytics, Depo-Provera contraceptive injection, antidepressants, antiemetics, Dalkon Shield, antidiabetic medications, phenylpropanolamine (PPA) and hormone replacement therapy for men and women.
Oliver v. Pharmacia & Upjohn Co., No. 06-5737, 2008 WL 4691626 (E.D. La. Oct 22, 2008).
Counsels Colville v. Pharmacia & Upjohn Co., 565 F. Supp. 2d 1314 (N.D. Fla. 2008).
Montagnon v. Pfizer, Inc., 584 F. Supp. 2d 459 (D. Conn. 2008).
Lorenzi v. Pfizer, Inc., 519 F. Supp. 2d 742 (N.D. Ohio 2007).
Taylor v. Pharmacia-Upjohn Co., No. 4:03CV148LN, 2005 WL 3502052 (S.D. Miss. Dec 19, 2005).